Bellevue Life Sciences Acquisition Corp. Rights
BLACR
BLACR was delisted on the 14th of February, 2025.
30 hedge funds and large institutions have $562K invested in Bellevue Life Sciences Acquisition Corp. Rights in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.
3% less funds holding
Funds holding: 31 → 30 (-1)
30% less capital invested
Capital invested by funds: $798K → $562K (-$236K)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$34.1K |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$10.1K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$3.36K |
| 4 |
FTUS
Flow Traders U.S.
New York
|
+$365 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$57.2K |
| 2 |
SOA
Sea Otter Advisors
Miami,
Florida
|
-$17.1K |
| 3 |
SFM
Spartan Fund Management
Toronto, Ontario,
Canada
|
-$9.88K |
| 4 |
EAM
Exos Asset Management
New York
|
-$2.88K |
| 5 |
CCM
Condor Capital Management
Martinsville,
New Jersey
|
-$1.41K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BI
26
Bulldog Investors
Saddle Brook,
New Jersey
| $1.96K | – | – | – |
|
|
WC
27
Wealthspring Capital
West Harrison,
New York
| $1.3K | -$485 | -3,550 | -22% |
|
|
FTUS
28
Flow Traders U.S.
New York
| $1K | +$365 | +2,671 | +23% |
|
29
Bank of America
Charlotte,
North Carolina
| $10 | – | – | – |
|
30
UBS Group
Zurich,
Switzerland
| $2 | – | – | – |
|
|
SOA
31
Sea Otter Advisors
Miami,
Florida
| – | -$17.1K | -122,000 | Closed |
|
|
SFM
32
Spartan Fund Management
Toronto, Ontario,
Canada
| – | -$9.88K | -69,076 | Closed |
|
|
CCM
33
Condor Capital Management
Martinsville,
New Jersey
| – | -$1.41K | -10,400 | Closed |
|
BLACR Hedge Fund Activity: Q2 2024 in Review
30 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Bellevue Life Sciences Acquisition Corp. Rights (BLACR) for Q2 2024, worth a combined $562K — down 30% from $798K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BLACR and 2 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 2 added.
The largest buyer was Cowen and Company, opening a new position worth an estimated $34.1K. The largest seller was Periscope Capital, cutting an estimated $57.2K.
- 30 institutional investors held Bellevue Life Sciences Acquisition Corp. Rights (BLACR) as of Q2 2024, down from 31 in Q1 2024.
- Funds reported $562K of Bellevue Life Sciences Acquisition Corp. Rights stock for Q2 2024, down 30% quarter-over-quarter.
- 2 funds opened new Bellevue Life Sciences Acquisition Corp. Rights positions in Q2 2024 and 3 closed out, a net change of -1 holder.
- The largest Bellevue Life Sciences Acquisition Corp. Rights buyer in Q2 2024 was Cowen and Company, an estimated $34.1K added.
- The largest Bellevue Life Sciences Acquisition Corp. Rights seller in Q2 2024 was Periscope Capital, an estimated $57.2K sold.
Based on aggregated 13F filings for Q2 2024.